Menu Search
Equities

RaySearch Laboratories AB (publ)

27R:DUS

RaySearch Laboratories AB (publ)

Actions
  • Price (EUR)16.56
  • Today's Change2.50 / 17.78%
  • Shares traded150.00
  • 1 Year change+123.18%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:32 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year RaySearch Laboratories AB (publ) grew revenues 21.16% from 843.65m to 1.02bn while net income improved 243.06% from 23.78m to 81.57m.
Gross margin90.48%
Net profit margin13.40%
Operating margin17.55%
Return on assets7.64%
Return on equity20.77%
Return on investment11.80%
More ▼

Cash flow in SEKView more

In 2023, RaySearch Laboratories AB (publ) increased its cash reserves by 114.44%, or 183.41m. The company earned 455.93m from its operations for a Cash Flow Margin of 44.60%. In addition the company used 209.33m on investing activities and also paid 56.35m in financing cash flows.
Cash flow per share12.24
Price/Cash flow per share12.37
Book value per share22.41
Tangible book value per share6.34
More ▼

Balance sheet in SEKView more

RaySearch Laboratories AB (publ) has a Debt to Total Capital ratio of 39.37%, a lower figure than the previous year's 67.67%.
Current ratio1.20
Quick ratio1.17
Total debt/total equity0.6494
Total debt/total capital0.3937
More ▼

Growth rates in SEK

SmartText is unavailable
Div yield(5 year avg)0.49%
Div growth rate (5 year)--
Payout ratio (TTM)45.34%
EPS growth(5 years)0.7648
EPS (TTM) vs
TTM 1 year ago		186.98
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.